Belmont Capital, LLC Ab Cellera Biologics Inc. Transaction History

Belmont Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$4.29 - $5.97 $1.07 Million - $1.49 Million	-250,000 Reduced 49.02%	260,000 $1.18 Million
Q3 2022 Oct 18, 2022	BUY	$9.2 - $13.68 $4.23 Million - $6.29 Million	460,000 Added 920.0%	510,000 $5.04 Million
Q2 2022 Jul 13, 2022	SELL	$5.72 - $10.65 $286,000 - $532,500	-50,000 Reduced 50.0%	50,000 $533,000
Q1 2022 Apr 26, 2022	SELL	$7.46 - $14.14 $373,000 - $707,000	-50,000 Reduced 33.33%	100,000 $975,000
Q2 2021 Jul 14, 2021	BUY	$20.19 - $34.17 $3.03 Million - $5.13 Million	150,000 New	150,000 $3.3 Million

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Belmont Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Belmont Capital, LLC with notifications on news.